Evidence map›Paper›PMID 35833668›Full record

ArticleWomen's health (London, England)

Premenstrual and menstrual changes reported after COVID-19 vaccination: The EVA project.

Laura Baena-García, Virginia A Aparicio, Ana Molina-López, Pilar Aranda, Laura Cámara-Roca, Olga Ocón-Hernández

Open access · goldAbstract read
In one paragraph

Article in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Impact of COVID-19 on Menstrual Cycle in Women.Journal of clinical medicine · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laura Baena-GarcíaDepartment of Nursing, Faculty of Health Sciences, University of Granada, Ceuta, Spain.ORCID 0000-0002-4895-567X
Virginia A AparicioSport and Health University Research Institute (iMUDS), Granada, Spain.
Ana Molina-LópezGynaecology and Obstetrics Unit, 'San Cecilio' University Hospital, Granada, Spain.ORCID 0000-0002-6211-9408
Pilar ArandaDepartment of Physiology, Faculty of Pharmacy, University of Granada, Granada, Spain.
Laura Cámara-RocaGynaecology and Obstetrics Unit, 'Virgen de las Nieves' University Hospital, Granada, Spain.
Olga Ocón-HernándeziInstituto de Investigación Biosanitaria, ibs. Granada, Spain.
Universidad de Granada · ESInstituto de Investigación Biosanitaria de Granada · ESHospital Universitario Virgen de las Nieves · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMenstrual disorders were not reported as a possible secondary effect in any of the clinical trials for the SARS-CoV-2 vaccines.

aimTo describe the prevalence of perceived premenstrual and menstrual changes after COVID-19 vaccine administration.

designCross-sectional study.

methodsA total of 14,153 women (mean age 31.5 ± 9.3 years old) who had received the full course of vaccination at least three months earlier were included in this cross-sectional study. Data including the type of vaccine administered, perceived changes in the amount and duration of menstrual bleeding, presence of clots, cycle length, and premenstrual symptoms were collected through a retrospective online survey from June to September 2021.

resultsOf the women who participated in this study, 3136 reported no menstrual changes and 11,017 (78% of the study sample) reported experiencing menstrual cycle changes after vaccination. In summary, women who reported menstrual changes after vaccination were older (overall

conclusionWomen vaccinated against COVID-19 usually perceive mild menstrual and premenstrual changes. Future studies are warranted to clarify the physiological mechanisms behind these widely reported changes.

Indexed as

COVID-19COVID-19 VaccinesMenstruation DisturbancesPremenstrual SyndromeAdultCross-Sectional StudiesFemaleHumansMenstrual CycleMenstruationRetrospective StudiesSARS-CoV-2VaccinationYoung AdultCOVID-19 Vaccinesfatigueimmunizationmenstrual bleedingmenstrual cyclepainSARS-CoV-2

Identifiers

PMID35833668
PMCPMC9289916
OpenAlexW4285491090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.